George F. Gao - Concepedia

Author

George F. Gao

Chinese Academy of Sciences ORCID

Also Known As

Beifen Shen, Elmoubasher Farag, Fu Gao, George, G F Gao, G Gao, G. F. Gao, G. Gao, G.F Gao, G.F. Gao, Gao, George

1.2K

Publications

153.2K

Citations

135

H-Index

325

Concepts

All Affiliations

Chinese Academy of Sciences Institute of Microbiology University of Chinese Academy of Sciences Chinese Center For Disease Control and Prevention National Institute for Viral Disease Control and Prevention

About

George F. Gao is an author at Chinese Academy of Sciences specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	88	291	48K
2	Engineering	12	12	1.2K
3	Health Sciences	10	10	679
4	Business	2	2	37
5	Language Studies	1	1	311

George F. Gao

659

Publications

125.4K

Citations

121

H-Index

Page 1

	Year	Citations
A Novel Coronavirus from Patients with Pneumonia in China, 2019 Na Zhu, Dingyu Zhang, Xingwang Li, New England Journal of Medicine	2020	30K
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia Qun Li, Xuhua Guan, Peng Wu, New England Journal of Medicine	2020	17.8K
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Roujian Lu, Xiang Zhao, Juan Li, The Lancet Viral EvolutionNovel CoronavirusVirus PhylogenyVirologyVirus Origins	2020	12.5K
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus Rongbao Gao, Bin Cao, Yunwen Hu, New England Journal of Medicine	2013	2.3K
Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010 Gonghuan Yang, Yu Wang, Yi‐Xin Zeng, The Lancet	2013	2K
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2 Rui Shi, Chao Shan, Xiaomin Duan, Nature Vaccine TargetImmunologyAntiviral ResponseVirologyHuman Neutralizing Antibody	2020	1.5K
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial Shengli Xia, Yuntao Zhang, Yanxia Wang, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentImmunologyVaccine Efficacy	2020	1.2K
Standardized assays for determining the catalytic activity and kinetics of peroxidase-like nanozymes Bing Jiang, Demin Duan, Lizeng Gao, Nature Protocols BiochemistryNatural SciencesBiocatalysisBioanalysisEnzyme Catalysis	2018	1.2K
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 Yan Wu, Feiran Wang, Chenguang Shen, Science Antibodies B38MedicineVaccine TargetViral PathogenesisImmunology	2020	1.1K
Emergence of Fatal PRRSV Variants: Unparalleled Outbreaks of Atypical PRRS in China and Molecular Dissection of the Unique Hallmark Kegong Tian, Xiuling Yu, Tiezhu Zhao, PLoS ONE Prrs VirusGeneticsMolecular DissectionPathologyViral Evolution	2007	1K

Page 1